Monoclonal Antibodies for COVID-19: New Avenues to Pre-Exposure Prophylaxis - Activity 3: Point-of-Care Use of Anti-SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis
| Overview / Abstract: |
As the COVID-19 pandemic continues to devastate the world, it is important for clinicians to recognize the most vulnerable populations, such as immunocompromised people. They are unlikely to mount a full response to COVID-19 vaccinations and have a higher risk of both severe outcomes if infected and easier transmission to uninfected people. An Emergency Use Authorization (EUA) was recently granted for preexposure prophylaxis in immunocompromised people, and it is critical that clinicians are aware of data, EUA criteria, and patient prioritization strategies. |
|
Expiration |
Apr 07, 2023 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Respiratory Therapy CE |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
0.25 |
|
Accreditation |
ACCME, AANP |
|
Presenters / Authors / Faculty |
Jonathan Li, MD, MMSc & Lewis Teperman, MD, FACS |
|
Sponsors / Supporters / Grant Providers |
This activity is jointly provided by Global Education Group and Integritas Communications. This educational activity is supported by an educational grant from AstraZeneca. |
|
Keywords / Search Terms |
Integritas Communications Integritas Communications Integritas Communications Anti-SARS-CoV-2, Monoclonal Antibodies, Pre-Exposure Prophylaxis, PrEP, COVID, COVID-19, Emergency Use Authorization, EUA, pandemic, vaccinations, ACCME, AANP, free credit, CME, CNE, continuing education, integritas communications Free CE CME, Immunocompromised Patients Free CE CME Free CE CME |
|